Dechra launches UK campaign to encourage equine strangles vaccination
Dechra Pharmaceuticals has launched a UK awareness campaign aimed at encouraging horse owners to discuss vaccination against strangles with their veterinarians. The initiative supports the company’s Strangvac vaccine and seeks to strengthen preventive disease management across the equine sector.
The campaign, titled Closing In, combines targeted digital advertising with educational resources for veterinary practices. It aims to improve understanding of strangles, its transmission and the potential consequences of outbreaks.
Strangles, caused by the bacterium Streptococcus equi, is a highly contagious equine disease that can disrupt training, competition and horse movements. Outbreaks can also impose significant costs on owners and equestrian facilities through isolation measures and operational restrictions.
Dechra’s campaign encourages horse owners to consider vaccination as part of a broader prevention strategy, alongside biosecurity and veterinary risk assessment.
Digital advertising will run until the end of December 2026, directing owners towards conversations with veterinary professionals about appropriate vaccination programmes.
The initiative reflects continued efforts by animal health companies to support vaccine uptake through disease education and veterinary engagement, particularly for conditions where outbreaks can have substantial welfare and economic consequences.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."